Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.

Despite antiretroviral therapy (ART), some HIV-infected persons maintain lower than normal CD4(+) T-cell counts in peripheral blood and in the gut mucosa. This incomplete immune restoration is associated with higher levels of immune activation manifested by high systemic levels of biomarkers, includ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irini Sereti, Jacob D Estes, William L Thompson, David R Morcock, Margaret A Fischl, Thérèse Croughs, Stéphanie Beq, Sylvie Lafaye de Micheaux, Michael D Yao, Alexander Ober, Eleanor M P Wilson, Ven Natarajan, Hiromi Imamichi, Mohamed R Boulassel, Michael M Lederman, Jean-Pierre Routy
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Acceso en línea:https://doaj.org/article/eb7c83c723e849f4957aae10ad49428d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eb7c83c723e849f4957aae10ad49428d
record_format dspace
spelling oai:doaj.org-article:eb7c83c723e849f4957aae10ad49428d2021-11-18T06:07:03ZDecreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.1553-73661553-737410.1371/journal.ppat.1003890https://doaj.org/article/eb7c83c723e849f4957aae10ad49428d2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24497828/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Despite antiretroviral therapy (ART), some HIV-infected persons maintain lower than normal CD4(+) T-cell counts in peripheral blood and in the gut mucosa. This incomplete immune restoration is associated with higher levels of immune activation manifested by high systemic levels of biomarkers, including sCD14 and D-dimer, that are independent predictors of morbidity and mortality in HIV infection. In this 12-week, single-arm, open-label study, we tested the efficacy of IL-7 adjunctive therapy on T-cell reconstitution in peripheral blood and gut mucosa in 23 ART suppressed HIV-infected patients with incomplete CD4(+) T-cell recovery, using one cycle (consisting of three subcutaneous injections) of recombinant human IL-7 (r-hIL-7) at 20 µg/kg. IL-7 administration led to increases of both CD4(+) and CD8(+) T-cells in peripheral blood, and importantly an expansion of T-cells expressing the gut homing integrin α4β7. Participants who underwent rectosigmoid biopsies at study baseline and after treatment had T-cell increases in the gut mucosa measured by both flow cytometry and immunohistochemistry. IL-7 therapy also resulted in apparent improvement in gut barrier integrity as measured by decreased neutrophil infiltration in the rectosigmoid lamina propria 12 weeks after IL-7 administration. This was also accompanied by decreased TNF and increased FOXP3 expression in the lamina propria. Plasma levels of sCD14 and D-dimer, indicative of systemic inflammation, decreased after r-hIL-7. Increases of colonic mucosal T-cells correlated strongly with the decreased systemic levels of sCD14, the LPS coreceptor - a marker of monocyte activation. Furthermore, the proportion of inflammatory monocytes expressing CCR2 was decreased, as was the basal IL-1β production of peripheral blood monocytes. These data suggest that administration of r-hIL-7 improves the gut mucosal abnormalities of chronic HIV infection and attenuates the systemic inflammatory and coagulation abnormalities that have been linked to it.Irini SeretiJacob D EstesWilliam L ThompsonDavid R MorcockMargaret A FischlThérèse CroughsStéphanie BeqSylvie Lafaye de MicheauxMichael D YaoAlexander OberEleanor M P WilsonVen NatarajanHiromi ImamichiMohamed R BoulasselMichael M LedermanJean-Pierre RoutyPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 10, Iss 1, p e1003890 (2014)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Irini Sereti
Jacob D Estes
William L Thompson
David R Morcock
Margaret A Fischl
Thérèse Croughs
Stéphanie Beq
Sylvie Lafaye de Micheaux
Michael D Yao
Alexander Ober
Eleanor M P Wilson
Ven Natarajan
Hiromi Imamichi
Mohamed R Boulassel
Michael M Lederman
Jean-Pierre Routy
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
description Despite antiretroviral therapy (ART), some HIV-infected persons maintain lower than normal CD4(+) T-cell counts in peripheral blood and in the gut mucosa. This incomplete immune restoration is associated with higher levels of immune activation manifested by high systemic levels of biomarkers, including sCD14 and D-dimer, that are independent predictors of morbidity and mortality in HIV infection. In this 12-week, single-arm, open-label study, we tested the efficacy of IL-7 adjunctive therapy on T-cell reconstitution in peripheral blood and gut mucosa in 23 ART suppressed HIV-infected patients with incomplete CD4(+) T-cell recovery, using one cycle (consisting of three subcutaneous injections) of recombinant human IL-7 (r-hIL-7) at 20 µg/kg. IL-7 administration led to increases of both CD4(+) and CD8(+) T-cells in peripheral blood, and importantly an expansion of T-cells expressing the gut homing integrin α4β7. Participants who underwent rectosigmoid biopsies at study baseline and after treatment had T-cell increases in the gut mucosa measured by both flow cytometry and immunohistochemistry. IL-7 therapy also resulted in apparent improvement in gut barrier integrity as measured by decreased neutrophil infiltration in the rectosigmoid lamina propria 12 weeks after IL-7 administration. This was also accompanied by decreased TNF and increased FOXP3 expression in the lamina propria. Plasma levels of sCD14 and D-dimer, indicative of systemic inflammation, decreased after r-hIL-7. Increases of colonic mucosal T-cells correlated strongly with the decreased systemic levels of sCD14, the LPS coreceptor - a marker of monocyte activation. Furthermore, the proportion of inflammatory monocytes expressing CCR2 was decreased, as was the basal IL-1β production of peripheral blood monocytes. These data suggest that administration of r-hIL-7 improves the gut mucosal abnormalities of chronic HIV infection and attenuates the systemic inflammatory and coagulation abnormalities that have been linked to it.
format article
author Irini Sereti
Jacob D Estes
William L Thompson
David R Morcock
Margaret A Fischl
Thérèse Croughs
Stéphanie Beq
Sylvie Lafaye de Micheaux
Michael D Yao
Alexander Ober
Eleanor M P Wilson
Ven Natarajan
Hiromi Imamichi
Mohamed R Boulassel
Michael M Lederman
Jean-Pierre Routy
author_facet Irini Sereti
Jacob D Estes
William L Thompson
David R Morcock
Margaret A Fischl
Thérèse Croughs
Stéphanie Beq
Sylvie Lafaye de Micheaux
Michael D Yao
Alexander Ober
Eleanor M P Wilson
Ven Natarajan
Hiromi Imamichi
Mohamed R Boulassel
Michael M Lederman
Jean-Pierre Routy
author_sort Irini Sereti
title Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
title_short Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
title_full Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
title_fullStr Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
title_full_unstemmed Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.
title_sort decreases in colonic and systemic inflammation in chronic hiv infection after il-7 administration.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/eb7c83c723e849f4957aae10ad49428d
work_keys_str_mv AT irinisereti decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT jacobdestes decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT williamlthompson decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT davidrmorcock decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT margaretafischl decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT theresecroughs decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT stephaniebeq decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT sylvielafayedemicheaux decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT michaeldyao decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT alexanderober decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT eleanormpwilson decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT vennatarajan decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT hiromiimamichi decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT mohamedrboulassel decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT michaelmlederman decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
AT jeanpierrerouty decreasesincolonicandsystemicinflammationinchronichivinfectionafteril7administration
_version_ 1718424574136156160